Skip to main content
. 2016 Aug 2;188(14):1004–1011. doi: 10.1503/cmaj.151483

Table 1:

Baseline characteristics of 5594 patients included in the final model

Characteristic Mean ± SD*
Follow-up time, yr 9.2 ± 2.9
Baseline age, yr 48.4 ± 6.8
Baseline FEV1, L 2.75 ± 0.63
FEV1, % of the predicted value 78.47 ± 9.06
Weight, kg 75.9 ± 15.1
Height, m 1.72 ± 0.09
Methacholine responsiveness (O’Connor slope) −12.73 (23.4)
Pack-years of smoking 40 ± 19
Sex, no. (%)
Male 3524 (63.0)
Female 2070 (37.0)
Smoking status by year 5, no. (%)
Sustained quitters 951 (17.0)
Intermittent quitters 1566 (28.0)
Continuous smokers 3077 (55.0)

Note: FEV1 = forced expiratory volume in 1 second, SD = standard deviation.

*

Unless stated otherwise.

After bronchodilator treatment.

Unit is change in FEV1 per mg/mL change in methacholine concentration.